Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Congenital Disorders of Glycosylation v0.69 XYLT2 Zornitza Stark Marked gene: XYLT2 as ready
Congenital Disorders of Glycosylation v0.69 XYLT2 Zornitza Stark Gene: xylt2 has been classified as Green List (High Evidence).
Congenital Disorders of Glycosylation v0.69 XYLT2 Zornitza Stark Phenotypes for gene: XYLT2 were changed from to Spondyloocular syndrome MIM# 605822
Congenital Disorders of Glycosylation v0.68 XYLT2 Zornitza Stark Classified gene: XYLT2 as Green List (high evidence)
Congenital Disorders of Glycosylation v0.68 XYLT2 Zornitza Stark Gene: xylt2 has been classified as Green List (High Evidence).
Congenital Disorders of Glycosylation v0.57 XYLT2 Paul De Fazio edited their review of gene: XYLT2: Changed phenotypes: Spondyloocular syndrome MIM# 605822
Congenital Disorders of Glycosylation v0.57 XYLT2 Paul De Fazio gene: XYLT2 was added
gene: XYLT2 was added to Congenital Disorders of Glycosylation. Sources: Literature
Mode of inheritance for gene: XYLT2 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: XYLT2 were set to 26027496; 26987875; 30891060; 28484880
Review for gene: XYLT2 was set to GREEN
gene: XYLT2 was marked as current diagnostic
Added comment: 5 unrelated individuals/families in total described with Spondylo-Ocular Syndrome (PMID: 26027496, 26987875, 30891060).

XYLT2-CDG has been referred to as a "proteoglycan ‘linker’ glycan disorder" (PMID: 28484880)
Sources: Literature